drugs

Showing 15 posts of 771 posts found.

novartis_window

Novartis becomes first to gain second CAR T indication

May 2, 2018
Research and Development, Sales and Marketing Gilead, Kymriah, Novartis, Yescarta, biotech, drugs, pharma, pharmaceutical

Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …

praluentalirocumab_1211441

Sanofi/Regeneron forced to slash price in wake of slow sales

May 1, 2018
Research and Development, Sales and Marketing Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical, praluent

Sanofi and Regeneron were touted as having a sure-fire blockbuster on their hands when they first brought Praluent to market …

ovariancancer

Ovarian cancer rates set to rise by 55%

May 1, 2018
Manufacturing and Production, Medical Communications biotech, drugs, ovarian cancer, pharma, pharmaceutical

Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type …

eye1

Novartis reveals more data for Eylea rival

May 1, 2018
Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical

Building on the back of strong data released at the end of last year, Novartis has released further positive Phase …

gandhi

Lilly hires new leader of immuno-oncology

May 1, 2018
Manufacturing and Production, Medical Communications Eli Lilly, biotech, drugs, immunoconlogy, immunotherapy, pharma, pharmaceutical

Immuno-oncology has become a huge area of the oncology market, led by the wave of PD-1/L1 drugs that are reaping …

medopad

Connecting patients to doctors

April 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …

piggy-2889042_960_720

Alzheon shies away from $81m IPO

April 30, 2018
Sales and Marketing Alzheon, biotech, drugs, pharma, pharmaceutical

Alzheon, a tiny biotech based in the Boston area, had initially launched its roadshow for an IPO potentially worth up …

canada_and_usa_flag

US applies pressure on Canada to stem cross-border generics flow

April 30, 2018
Sales and Marketing Canada, IP, US, biotech, drugs, pharma, pharmaceutical

The US has upped the ante against Canada to secure stronger border checks for pharmaceutical goods by adding the country …

becca

Health to hand

April 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Breast Cancer Care, biotech, drugs, pharma, pharmaceutical

Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …

houses-of-parliament-1055056_960_720

House of Lords unloads both barrels on Government’s life science strategy approach

April 26, 2018
Medical Communications ABPI, Life Sciences Industrial Strategy, UK government, biotech, drugs, pharma, pharmaceutical

The Life Sciences Industrial Strategy was supposed to forge a path forward for the industry, despite pressures from Brexit, to …

Takeda announce new UK MD, ahead of possible Shire transformation

April 26, 2018
Medical Communications Shire, Takeda, biotech, drugs, pharma, pharmaceutical

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

hands-981400_960_720

Common antidepressants linked to dementia risk

April 26, 2018
Medical Communications anticholinergic, biotech, dementia, drugs, pharma, pharmaceutical

A large study looking at the public’s use of anticholinergic drugs, such as those used to treat depression and Parkinson’s, …

phone_health

Novartis forges forward into digital pharma with FocalView app

April 25, 2018
Medical Communications, Research and Development FocalView, Novartis, biotech, drugs, pharma, pharmaceutical

There is a growing trend in big pharma to talk up the potential for digital technology to revolutionise operations and …

john_reed

Sanofi makes ex-Roche scientist new R&D chief

April 25, 2018
Medical Communications, Research and Development Roche, Sanofi, biotech, drugs, pharma, pharmaceutical

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

china_block_001_takeda

$64bn Takeda-Shire mega merger inches closer to closing

April 25, 2018
Research and Development, Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …

The Gateway to Local Adoption Series

Latest content